• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


AxoGen, Inc. To Open New Distribution Facility in Burleson, Texas

AxoGen, Inc., a firm that focuses on the science and commercialization of surgical solutions for peripheral nerve repair, plans to open a distribution facility in Burleson, Texas.

The company leased a distribution facility in Burleson to accommodate product distribution and raw material storage. “The Burleson facility will support the Company’s growing business and enable improved customer service, including the ability to fulfill same day orders for both coasts of the United States,” company officials said. The first shipment from the new facility is anticipated in the first quarter of 2014 after all regulatory approvals are obtained.

Greg Freitag, AxoGen Chief Financial Officer said, “The new distribution facility in Burleson is an important component of our continued growth and includes attractive incentives from the local Economic Development Program. Burleson is an ideal partner in terms of location and accessibility allowing us to process late night orders and meet demand for delivery of nerve repair products throughout the United States, including the West Coast. The new distribution facility will also allow us to consolidate our raw material storage and reduce storage expense.”

“Burleson City Leadership including the Mayor, City Council and Economic Development Team fully understood the requirements of AxoGen as a rapidly growing company and worked closely with us to support the creation of our new distribution facility. We are extremely excited to become part of the Burleson community and look forward to a long and productive partnership,” he added.

Bradley Ford, the city’s Director of Development Services said; “We welcome AxoGen as an essential member of our community. Burleson and AxoGen share a common story of a progressive vision and remarkable growth. We look forward to playing a large part in AxoGen’s promising future. We support the Company’s goal of Providing surgeons with solutions to repair and protect peripheral nerves and ultimately change the standard of care for patients with peripheral nerve injuries.”

AxoGen will continue to maintain its corporate headquarters in Alachua, Florida. Under the city’s Economic Development Program, AxoGen will receive certain economic incentives that will offset a portion of the costs to establish the facility, along with the opportunity to obtain further incentives depending on hiring, training and future operations.


Exclusive Research